Search

Little is known about the transport and fate of aerosolized particles associated with harmful algal blooms (HABs). An Airborne DROne Particle-monitoring System (AirDROPS) was developed and used to monitor, collect, and characterize airborne particles over two HABs in Grand Lake St Marys (GLSM) and Lake Erie (LE), Ohio USA in August 2019. The AirDROPS consisted of an impinging device (ID) and an optical particle counter (OPC) mounted on a large commercial quadcopter (DJI Inspire 2). The sensor package was mounted above the airframe to limit the effects of propeller downwash that can corrupt measurements taken below the drone. Nineteen flights were conducted 10 m above water level (AWL) at GLSM, and five flights were conducted 10 m AWL at LE. The sampling height was chosen to minimize the effects of propwash on aerosolization from the lake surface. One intercomparison flight was conducted at GLSM over land adjacent to a sonic anemometer mounted on the top of a flagpole 15 m above ground level (AGL). Particle counts generally decreased from morning to afternoon flights, ranging from >4000 in the morning to 4000 below 4 m s−1 to

The risk of human exposure to cyanotoxins is partially influenced by the location of toxin-producing cyanobacteria in waterbodies. Cyanotoxin production can occur throughout the water column, with deep water production representing a potential public health concern, specifically for drinking water supplies. Deep cyanobacteria layers are often unreported, and it remains to be seen if lower incident rates reflect an uncommon phenomenon or a monitoring bias. Here, we examine Sunfish Lake, Ontario, Canada as a case study lake with a known deep cyanobacteria layer. Cyanotoxin and other bioactive metabolite screening revealed that the deep cyanobacteria layer was toxigenic [0.03 μg L

Cyanotoxins called microcystins (MCs) are highly toxic and can be present in drinking water sources. Determining the structure of MCs is paramount because of its effect on toxicity. Though over 300 MC congeners have been discovered, many remain unidentified. Herein, a method is described for the putative identification of MCs using liquid chromatography (LC) coupled with high-resolution (HR) Orbitrap mass spectrometry (MS) and a new bottom-up sequencing strategy. Maumee River water samples were collected during a harmful algal bloom and analyzed by LC-MS with simultaneous HRMS and MS/MS. Unidentified ions with characteristic MC fragments (135 and 213

Cyanobacterial biomass forecasts currently cannot predict the concentrations of microcystin, one of the most ubiquitous cyanotoxins that threaten human and wildlife health globally. Mechanistic insights into how microcystin production and biodegradation by heterotrophic bacteria change spatially and throughout the bloom season can aid in toxin concentration forecasts. We quantified microcystin production and biodegradation during two growth seasons in two western Lake Erie sites with different physicochemical properties commonly plagued by summer

Monitoring of cyanobacterial bloom biomass in large lakes at high resolution is made possible by remote sensing. However, monitoring cyanobacterial toxins is only feasible with grab samples, which, with only sporadic sampling, results in uncertainties in the spatial distribution of toxins. To address this issue, we conducted two intensive “HABs Grabs” of microcystin (MC)-producing Microcystis blooms in the western basin of Lake Erie. These were one-day sampling events during August of 2018 and 2019 in which 100 and 172 grab samples were collected, respectively, within a six-hour window covering up to 2,270 km2 and analyzed using consistent methods to estimate the total mass of MC. The samples were analyzed for 57 parameters, including toxins, nutrients, chlorophyll, and genomics. There were an estimated 11,513 kg and 30,691 kg of MCs in the western basin during the 2018 and 2019 HABs Grabs, respectively. The bloom boundary poses substantial issues for spatial assessments because MC concentration varied by nearly two orders of magnitude over very short distances. The MC to chlorophyll ratio (MC:chl) varied by a factor up to 5.3 throughout the basin, which creates challenges for using MC:chl to predict MC concentrations. Many of the biomass metrics strongly correlated (r > 0.70) with each other except chlorophyll fluorescence and phycocyanin concentration. While MC and chlorophyll correlated well with total phosphorus and nitrogen concentrations, MC:chl correlated with dissolved inorganic nitrogen. More frequent MC data collection can overcome these issues, and models need to account for the MC:chl spatial heterogeneity when forecasting MCs.

Microcystin-LR (MC-LR) is a cyclic hepatotoxin produced by cyanobacteria, including Microcystis sp. and Planktothrix sp. Harmful algal blooms (HABs) in Lake Erie have become a major human health concern in recent years, highlighted by the August 2014 city of Toledo, Ohio, municipal water “do not drink” order that affected nearly 500,000 residents for 3 days. Given that microcystin degrading bacteria have been reported from HAB-affected waters around the world, we hypothesized that MC-LR degrading bacteria could be isolated from Lake Erie. To test this hypothesis, 13 water samples were collected from various Lake Erie locations during the summers of 2014 and 2015, MC-LR was continuously added to each water sample for 3 to 5 weeks to enrich for MC-LR-degrading bacteria, and MC-LR was quantitated over time. Whereas MC-LR was relatively stable in sterile-filtered lake water, robust MC-LR degradation (up to 19 ppb/day) was observed in some water samples. Following the MC-LR selection process, 67 individual bacterial isolates were isolated from MC-LR degrading water samples and genotyped to exclude potential human pathogens, and MC-LR degradation by smaller groups of bacterial isolates (e.g., groups of 22 isolates, groups of 11 isolates, etc.) was examined. Of those smaller groups, selected groups of four to five bacterial isolates were found to degrade MC-LR into non-toxic forms and form robust biofilms on siliconized glass tubes. Taken together, these studies support the potential use of isolated bacterial isolates to remove MC-LR from drinking water.

A method was developed to extract and quantify microcystins (MCs) from mouse liver with limits of quantification (LOQs) lower than previously reported. MCs were extracted from 40-mg liver samples using 85:15 (v:v) CH3CN:H2O containing 200 mM ZnSO4 and 1% formic acid. Solid-phase extraction with a C18 cartridge was used for sample cleanup. MCs were detected and quantified using HPLC-orbitrap-MS with simultaneous MS/MS detection of the 135.08 m/z fragment from the conserved Adda amino acid for structural confirmation. The method was used to extract six MCs (MC-LR, MC-RR, MC-YR, MC-LA, MC-LF, and MC-LW) from spiked liver tissue and the MC-LR cysteine adduct (MC-LR-Cys) created by the glutathione detoxification pathway. Matrix-matched internal standard calibration curves were constructed for each MC (R2 &ge, 0.993), with LOQs between 0.25 ng per g of liver tissue (ng/g) and 0.75 ng/g for MC-LR, MC-RR, MC-YR, MC-LA, and MC-LR-Cys, and 2.5 ng/g for MC-LF and MC-LW. The protocol was applied to extract and quantify MC-LR and MC-LR-Cys from the liver of mice that had been gavaged with 50 &micro, g or 100 &micro, g of MC-LR per kg bodyweight and were euthanized 2 h, 4 h, or 48 h after final gavage. C57Bl/6J (wild type, control) and Leprdb/J (experiment) mice were used as a model to study non-alcoholic fatty liver disease. The Leprdb/J mice were relatively inefficient in metabolizing MC-LR into MC-LR-Cys, which is an important defense mechanism against MC-LR exposure. Trends were also observed as a function of MC-LR gavage amount and time between final MC-LR gavage and euthanasia/organ harvest.

Harmful algal blooms (HABs) caused by cyanobacteria in freshwater environments produce toxins (e.g., microcystin) that are harmful to human and animal health. HAB frequency and intensity are increasing with greater nutrient runoff and a warming climate. Lake spray aerosol (LSA) released from freshwater lakes has been identified on lakeshores and after transport inland, including from lakes with HABs, but little is known about the potential for HAB toxins to be incorporated into LSA. In this study, freshwater samples were collected from two lakes in Michigan: Mona Lake during a severe HAB with microcystin concentrations (>200 μg/L) well above the Environmental Protection Agency (EPA) recommended "do not drink" level (1.6 μg/L) and Muskegon Lake without a HAB (

Background Epidemiological studies have shown Per- and polyfluoroalkyl substances (PFAS) to be associated with diseases of dysregulated lipid and sterol homeostasis such as steatosis and cardiometabolic disorders. However, the majority of mechanistic studies rely on single chemical exposures instead of identifying mechanisms related to the toxicity of PFAS mixtures. Objectives The goal of the current study is to investigate mechanisms linking exposure to a PFAS mixture with alterations in lipid metabolism, including increased circulating cholesterol and bile acids. Methods Male and female wild-type C57BL/6J mice were fed an atherogenic diet used in previous studies of pollutant-accelerated atherosclerosis and exposed to water containing a mixture of 5 PFAS representing legacy, replacement, and alternative subtypes (i.e., PFOA, PFOS, PFNA, PFHxS, and GenX), each at a concentration of 2 mg/L, for 12 weeks. Changes at the transcriptome and metabolome level were determined by RNA-seq and high-resolution mass spectrometry, respectively. Results We observed increased circulating cholesterol, sterol metabolites, and bile acids due to PFAS exposure, with some sexual dimorphic effects. PFAS exposure increased hepatic injury, demonstrated by increased liver weight, hepatic inflammation, and plasma alanine aminotransferase levels. Females displayed increased lobular and portal inflammation compared to the male PFAS-exposed mice. Hepatic transcriptomics analysis revealed PFAS exposure modulated multiple metabolic pathways, including those related to sterols, bile acids, and acyl carnitines, with multiple sex-specific differences observed. Finally, we show that hepatic and circulating levels of PFOA were increased in exposed females compared to males, but this sexual dimorphism was not the same for other PFAS examined. Discussion Exposure of mice to a mixture of PFAS results in PFAS-mediated modulation of cholesterol levels, possibly through disruption of enterohepatic circulation.

Cyanobacterial blooms and the associated hepatotoxins produced (e.g., microcystins, MCs) create a significant human health risk in freshwater lakes around the world, including Lake Erie. Though various physical and chemical treatment options are utilized, these are costly and their effectiveness decreases when other organics are present. Laboratory studies have identified a remediation option based on a mlr gene operon that can systematically degrade this toxin; however, studies on Lake Erie have been unable to amplify mlr genes from MC-degrading bacteria. These results suggest that either existing primers may be inefficient for broad identification of the mlr genes or that MC degradation genes and/or pathways may vary among bacterial taxa. To investigate the dynamics of the Lake Erie microbial community involved in the degradation of microcystin-LR (MC-LR), a flow-through column experiment using collected beach sand was conducted over a period of six weeks. Increasing concentrations of lake water spiked with MC-LR were continuously delivered to both biotic and abiotic (sterilized) sand columns, with influent and effluent MC-LR concentrations measured by LC-MS/MS. Despite the toxin concentrations far exceeding natural conditions during a bloom event (maximum dosage = 15.4 μg/L), MC-LR was completely removed within 21 h of contact time in the biotic columns. Stimulation of community taxa during the degradation process included Burkholderiaceae, Illumatobacteraceae, Pseudomonadaceae, Rhodocyclaceae and Nitrosomonadaceae. The overall results suggest several critical species may be required for the most complete and effective degradation of MC-LR.

To achieve quantitative measurements of neurotransmitters, researchers employ analytical methods based on balancing the amenability and limitations of a technique for a specific application. In particular, in vivo microdialysis sampling has proven indispensable toward improving our understanding of the biological roles mediated by diverse neuroactive compounds. This chapter discusses the development and application of liquidchromatography methods for analysis of a broad range of neurotransmitters and their metabolites from tissue and dialysate samples in both experimental and clinical settings. Liquid chromatography-based methods are capable of resolving neurotransmitters from complex biological matrices and offer flexibility in coupling to various detection techniques, such as mass spectrometry, electrochemical, and fluorescence. Improved column technologies and separation conditions offer increased efficiency for chromatographic resolution, decreased separation time, improved temporal resolution, and enhanced multianalyte capability. Together, microdialysis sampling and liquid chromatography-based methods continue to be principle techniques widely employed to examine neurotransmitter function in the central nervous system.

Brain-derived neurotrophic factor (BDNF) modulates the synaptic transmission of several monoaminergic neuronal systems, including forebrain dopamine-containing neurons. Recent evidence shows a strong correlation between neuropsychiatric disorders and BDNF hypofunction. The aim of the present study was to characterize the effect of low endogenous levels of BDNF on dopamine system function in the caudate-putamen using heterozygous BDNF (BDNF(+/-) ) mice. Apparent extracellular dopamine levels in the caudate-putamen, determined by quantitative microdialysis, were significantly elevated in BDNF(+/-) mice compared with wildtype controls (12 vs. 5 nM, respectively). BDNF(+/-) mice also had a potentiated increase in dopamine levels following potassium (120 mM)-stimulation (10-fold) relative to wildtype controls (6-fold). Slice fast-scan cyclic voltammetry revealed that BDNF(+/-) mice had reductions in both electrically evoked dopamine release and dopamine uptake rates in the caudate-putamen. Superfusion of BDNF led to partial recovery of the electrically stimulated dopamine release response in BDNF(+/-) mice. Conversely, tissue accumulation of L-3,4-dihydroxyphenylalanine, extracellular levels of dopamine metabolites, and spontaneous locomotor activity were unaltered. Together, this study indicates that endogenous BDNF influences dopamine system homeostasis by regulating the release and uptake dynamics of pre-synaptic dopamine transmission.

The risk of developing neurologic diseases and disorders differs between men and women. For example, men are approximately 1.5 times more likely than women to develop Parkinson’s disease, which is characterized by dopamine (DA) neuron degeneration in the striatum.1 Furthermore, women are twice as likely to develop depressive disorders compared to men.2 To better understand sex differences in these neurologic conditions, research has focused on the molecules implicated in these conditions, such as the neurotransmitters DA and serotonin, as well as the neurotrophic factors involved in the growth, differentiation, plasticity, and protection of neurons, like brain-derived neurotrophic factor (BDNF).3−5 To better understand sex differences in disease risk and progression, gonadal hormones such as estrogen and testosterone have also been investigated. In ovariectomized rats, a physiologic dose of estrogen increases striatal extracellular DA concentrations and tyrosine hydroxylase activity.6 Furthermore, estrogen stimulates similar downstream second messengers, ERK1 and ERK2, in a manner analogous to BDNF in cortical explant cultures.7 Additionally, female rats show increased depression vulnerability relative to their male counterparts when their BDNF levels are at their lowest, which correlates with their maximum estrogen levels.8−10 Sex differences are also observed in neurologic disorders such as addiction, with women and men responding differently to drugs of abuse. For example, in clinical studies, women are more likely to start using illicit drugs sooner and in greater quantities than men,11,12 whereas men are more likely to die from an overdose than women.13 In animal models, males are more susceptible to the neurotoxic effects of methamphetamine (METH) than females, as shown by reduced striatal DA and DA transporter (DAT) binding.14−16 These observations in animal and clinical studies, along with others using METH and incorporating estrogen and testosterone, have suggested that females may be protected from the harmful effects of drugs because of their naturally higher of estrogen levels.15,17,18 Numerous studies have elucidated the importance of BDNF in maintaining the function and survival of striatal DA neurons.19−22 To better understand the endogenous role of BDNF throughout the brain and body, we used genetically modified heterozygous (BDNF+/–) mice developed by Ernfors and colleagues.23 Male BDNF+/– mice have increased extracellular and intracellular DA levels compared to their male wildtype littermates,21,24,25 which are not associated with alterations in DAT. The objective of this study was to determine if these striatal DA alterations are present in female BDNF+/– mice. Using the complementary techniques of in vivo microdialysis and slice fast scan cyclic voltammetry (FSCV), we investigated DA dynamics in female wildtype and BDNF+/– mice.

A recently available boron-doped diamond (BDD) working electrode has been developed for use with high-performance liquid chromatography (HPLC) to aid in the detection of molecules with high redox potentials. In this work, we developed a method using a commercially available BDD working electrode for detecting neurotransmitters from two different families with large oxidation potential differences, namely, dopamine (DA) and adenosine (Ado). Hydrodynamic voltammograms were constructed for DA and Ado, and the optimal potentials for the detection of DA and Ado were determined to be +740 and +1200 mV versus a palladium reference electrode, respectively. A working potential of +840 mV was chosen, and the detection range achieved with the BDD electrode for DA and Ado was from low nanomolar to high millimolar levels. To determine the practical function of the BDD electrode, tissue content was analyzed for seven monoamine and two purine molecules, which were resolved in a single run in less than 28 min. Our results demonstrate that the BDD electrode is sensitive and robust enough to detect monoamine and purine molecules from frontal cortex and striatal mouse samples. Using a BDD electrode opens the possibility of exploring multiple classes of neurotransmitters in a single run using electrochemical detection to probe their interactions.